Audrey Vardy

1.2k total citations
25 papers, 788 citations indexed

About

Audrey Vardy is a scholar working on Pharmacology, Molecular Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Audrey Vardy has authored 25 papers receiving a total of 788 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pharmacology, 5 papers in Molecular Biology and 5 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Audrey Vardy's work include Pharmacogenetics and Drug Metabolism (10 papers), Eicosanoids and Hypertension Pharmacology (5 papers) and Carcinogens and Genotoxicity Assessment (3 papers). Audrey Vardy is often cited by papers focused on Pharmacogenetics and Drug Metabolism (10 papers), Eicosanoids and Hypertension Pharmacology (5 papers) and Carcinogens and Genotoxicity Assessment (3 papers). Audrey Vardy collaborates with scholars based in United Kingdom, United States and Germany. Audrey Vardy's co-authors include Jeremy J. Lambert, Dianne R. Peden, Delia Belelli, John A. Peters, Luc J. Gentet, Elizabeth A. Mitchell, Murray B. Herd, Brian G. Lake, Clifford R. Elcombe and John A. Peters and has published in prestigious journals such as Neuroscience, Progress in Neurobiology and Toxicology and Applied Pharmacology.

In The Last Decade

Audrey Vardy

20 papers receiving 774 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Audrey Vardy United Kingdom 11 324 220 147 115 93 25 788
Ruither Oliveira Gomes Carolino Brazil 17 174 0.5× 156 0.7× 122 0.8× 75 0.7× 38 0.4× 29 685
Qi‐Xin Zhou China 23 459 1.4× 433 2.0× 205 1.4× 117 1.0× 127 1.4× 71 1.4k
D.S. Kerr New Zealand 12 196 0.6× 171 0.8× 151 1.0× 57 0.5× 17 0.2× 20 576
Shigeo Miyata Japan 17 248 0.8× 181 0.8× 112 0.8× 58 0.5× 39 0.4× 39 675
Kinga Gaweł Poland 17 361 1.1× 337 1.5× 97 0.7× 65 0.6× 44 0.5× 48 1000
Ewa Litwa Poland 21 275 0.8× 285 1.3× 174 1.2× 94 0.8× 12 0.1× 46 964
Ashley S. Murr United States 14 79 0.2× 137 0.6× 117 0.8× 115 1.0× 26 0.3× 27 1.1k
Michael Ansonoff United States 17 515 1.6× 461 2.1× 125 0.9× 83 0.7× 182 2.0× 24 1.1k
H. Parvez France 19 318 1.0× 286 1.3× 107 0.7× 69 0.6× 31 0.3× 86 1.3k
Hussien Al‐Shamma United States 15 212 0.7× 210 1.0× 97 0.7× 181 1.6× 14 0.2× 20 814

Countries citing papers authored by Audrey Vardy

Since Specialization
Citations

This map shows the geographic impact of Audrey Vardy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Audrey Vardy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Audrey Vardy more than expected).

Fields of papers citing papers by Audrey Vardy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Audrey Vardy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Audrey Vardy. The network helps show where Audrey Vardy may publish in the future.

Co-authorship network of co-authors of Audrey Vardy

This figure shows the co-authorship network connecting the top 25 collaborators of Audrey Vardy. A scholar is included among the top collaborators of Audrey Vardy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Audrey Vardy. Audrey Vardy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Lake, Brian G., et al.. (2020). Piperonyl butoxide: Mode of action analysis for mouse liver tumour formation and human relevance. Toxicology. 439. 152465–152465. 9 indexed citations
4.
Wiemann, Christiane, Audrey Vardy, Barbara M. Elcombe, et al.. (2019). Metazachlor: Mode of action analysis for rat liver tumour formation and human relevance. Toxicology. 426. 152282–152282. 10 indexed citations
5.
6.
7.
Brown, Susan J., et al.. (2018). Metabolism of deltamethrin andcis- andtrans-permethrin by rat and human liver microsomes, liver cytosol and plasma preparations. Xenobiotica. 49(4). 388–396. 14 indexed citations
8.
9.
Brown, Susan J., Annette MacLeod, Audrey Vardy, et al.. (2018). Metabolism of deltamethrin and cis- and trans-permethrin by human expressed cytochrome P450 and carboxylesterase enzymes. Xenobiotica. 49(5). 521–527. 19 indexed citations
10.
Rushton, Erik, et al.. (2017). Mode of action and human relevance of THF-induced mouse liver tumors. Toxicology Letters. 276. 138–143. 15 indexed citations
11.
Sakaguchi, Tadashi, et al.. (2015). Risk assessment of zero-flow ventilation strategy for fires in bidirectional tunnels with longitudinal ventilation. Discovery Research Portal (University of Dundee). 501–516. 5 indexed citations
12.
13.
LeBaron, Matthew J., David R. Geter, Reza J. Rasoulpour, et al.. (2013). An integrated approach for prospectively investigating a mode-of-action for rodent liver effects. Toxicology and Applied Pharmacology. 270(2). 164–173. 28 indexed citations
14.
Ichikawa, A. K., et al.. (2011). Application of MPVC to the two longest road tunnels in Japan. Discovery Research Portal (University of Dundee). 419–430.
15.
Murakami, Kenichi, et al.. (2009). The use of inverter-driven jet-fans to reduce tunnel ventilation costs. Discovery Research Portal (University of Dundee). 69–80. 1 indexed citations
16.
Vardy, Audrey, et al.. (2009). An in vitro model for the prediction of chemical metabolism and toxicity. Toxicology. 262(1). 23–23. 4 indexed citations
17.
Belelli, Delia, Murray B. Herd, Elizabeth A. Mitchell, et al.. (2005). Neuroactive steroids and inhibitory neurotransmission: Mechanisms of action and physiological relevance. Neuroscience. 138(3). 821–829. 132 indexed citations
18.
Lambert, Jeremy J., Delia Belelli, Dianne R. Peden, Audrey Vardy, & John A. Peters. (2003). Neurosteroid modulation of GABAA receptors. Progress in Neurobiology. 71(1). 67–80. 413 indexed citations
19.
Vardy, Audrey, et al.. (1992). LONG-TERM USE OF FLUVOXAMINE (FL) IN OBSESSIVE COMPULSIVE DISORDER (OCD): SUSTAINED EFFICACY AND GOOD TOLERABILITY. Clinical Neuropharmacology. 15. 312B–312B. 1 indexed citations
20.
Holland, R. L., et al.. (1992). FLUVOXAMINE (FL): AN EFFECTIVE TREATMENT FOR OBSESSIVE COMPULSIVE DISORDER (OCD). Clinical Neuropharmacology. 15. 313B–313B. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ruither Oliveira Gomes Carolino Breakdown of academic impact, for papers by Qi‐Xin Zhou Breakdown of academic impact, for papers by D.S. Kerr Breakdown of academic impact, for papers by Shigeo Miyata Breakdown of academic impact, for papers by Kinga Gaweł Breakdown of academic impact, for papers by Ewa Litwa Breakdown of academic impact, for papers by Ashley S. Murr Breakdown of academic impact, for papers by Michael Ansonoff Breakdown of academic impact, for papers by H. Parvez Breakdown of academic impact, for papers by Hussien Al‐Shamma
Rankless by CCL
2026